Inventor · disambiguated record
Yuji Naito
Also filed as: NAITO YUJI
4 granted patents·7 pending applications·1 citations·filing 2006–2020
59Inventor score
Top patents by PatentIndex Score
11 records- 0177US10828269B2Reducing muscle atrophy by administering astaxanthinFUJI CHEM IND CO LTD·Filed 2014·Granted Nov 10, 2020·1 cites·7 claims
- 0265US2009299036A1Agent for preventing arteriosclerosis, agent for suppressing vascular intimal thickening and agent for improving vascular endothelial functionCALPIS CO LTD·Filed 2007·Application pending·0 cites
- 0364US2021008009A1Gene expression regulating agentFUJI CHEM IND CO LTD·Filed 2020·Application pending·0 cites
- 0459US2008269349A1Gene expression regulating agentFUJI CHEM IND CO LTD·Filed 2008·Application pending·0 cites
- 0559US2012035096A1Agent for preventing arteriosclerosis, agent for suppressing vascular intimal thickening and agent for improving vascular endothelial functionHIROTA TATSUHIKO·Filed 2011·Application pending·0 cites
- 0655US8309576B2Method of treating inflammatory bowel diseaseNAITO YUJI·Filed 2008·Granted Nov 13, 2012·0 cites·11 claims
- 0755US2021052516A1Method for increasing akkermansia in intestinal bacterial flora by ingesting astaxanthinFUJI CHEM IND CO LTD·Filed 2020·Application pending·0 cites
- 0853US11576929B2Composition for inflammatory gastrointestinal disordersSUMITOMO SEIKA CHEMICALS·Filed 2019·Granted Feb 14, 2023·0 cites·10 claims
- 0952US2007060647A1Gene expression regulating agentYUJI NAITO·Filed 2006·Application pending·0 cites
- 1051US2015307549A1Agent for preventing arteriosclerosis, agent for suppressing vascular intimal thickening and agent for improving vascular endothelial functionCALPIS CO LTD·Filed 2015·Application pending·0 cites
- 1150US10894022B2Method for increasing Akkermansia in intestinal bacterial flora by ingesting astaxanthinFUJI CHEM IND CO LTD·Filed 2018·Granted Jan 19, 2021·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Yuji Naito files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →